ArticleAsia-Pacific journal of oncology nursing2025
Fear of cancer recurrence in patients with early-stage non-small cell lung cancer: A latent profile analysis.
Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The mediating role of resourcefulness in the relationship between perceived stress and benefit finding among non-small cell lung cancer patients: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Prognostic factors in early-stage lung adenocarcinoma: a multicenter study prognostic markers in early lung adenocarcinoma.Journal of cardiothoracic surgery · 2026Article
- Fear of cancer recurrence mediates the association between symptom burden and readiness for return to work in patients with lung cancer.Asia-Pacific journal of oncology nursing · 2025Article
- The impact of illness perception on quality of life in lung cancer chemotherapy patients: mediating effect of fear of progression.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify latent profiles of fear of cancer recurrence (FCR) among patients with early-stage non-small cell lung cancer (NSCLC) and examine the associated factors. Methods: A cross-sectional survey was conducted with 677 patients with early-stage NSCLC who underwent surgical treatment at a tier-three cancer hospital in Beijing between January 2022 and August 2023. Data collection included demographic variables and assessments using the Fear of Progression Questionnaire-Short Form (FoP-Q-SF), Herth Hope Index (HHI), and Social Support Rating Scale (SSRS). Latent profile analysis was employed to classify FCR levels and identify influencing factors. Results: Three distinct FCR profiles emerged: "low FCR" (27.6%), "moderate FCR" (66.2%), and "high FCR" (6.2%). Independent risk factors for moderate FCR included individuals aged 36-60 years (odds ratio [OR] = 1.871, 95% confidence interval [CI] 1.208-2.899) and a household income below 5000 yuan (OR = 1.86, 95% CI 1.059-3.267). Protective factors for moderate FCR included lower levels of education (OR = 0.505, 95% CI 0.283-0.902), religious beliefs (OR = 0.355, 95% CI 0.152-0.833), and smoking (OR = 0.461, 95% CI 0.284-0.747). High FCR was strongly associated with being 36-60 years old, lower HHI scores (OR = 11.055, 95% CI 4.441-27.522), and poor social support (OR = 3.392, 95% CI 1.385-8.308). Conclusions: FCR among patients with early-stage NSCLC can be categorized into distinct profiles, with specific demographic and psychosocial factors influencing severity. Tailored nursing interventions addressing varying FCR levels are critical to improving patient care and psychological well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.